patent
Judge reverses verdict in MSD/Gilead hepatitis C dispute
June 7, 2016Manufacturing and Production, Research and Development, Sales and Marketing Gilead, MSD, Merck, dispute, patent, reversal, sovaldi
A US district judge has reversed a previous court decision which favoured MSD, called Merck in the US, over Gilead …
Gilead’s Sovaldi gets Indian patent; critics call it “major blow” to patient access
May 11, 2016Manufacturing and Production, Research and Development, Sales and Marketing India, harm, hepatitis, patent, patient access, sovaldi
Gilead has been granted a patent for its hepatitis C drug, Sovaldi (sofosbuvir), in India which has sparked dismay among …
Baxalta sues Chugai for haemophilia drug patent breach
May 11, 2016Research and Development Baxalta, Chugai, breach, court, haemophilia, infringe, infringement, patent, sue, suing
Baxalta has taken Chugai Pharmaceuticals to the Tokyo district court, claiming that the Japanese company has infringed upon its patent …
Google files for US patent to electronic eye lens
May 3, 2016Manufacturing and Production, Research and Development Alphabet, google, lens, patent, research
Alphabet Inc (Nasdaq: GOOG) has filed a patent application for a device that can be implanted in the eye to …
Allergan launches Crestor generic in the US
May 3, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, AstraZeneca, Crestor, FDA, FDA Approval, cholesterol, generic, patent, patent expiry, sales
Allergan has received FDA approval on the generic version of AstraZeneca’s high cholesterol drug, Crestor (rosuvastatin), and has become the …
Roche sues Intas Pharma over patent dispute in India
April 18, 2016Medical Communications, Sales and Marketing India, Roche, anaemia, chronic kidney, intas, intas pharmaceuticals, patent
Roche Pharmaceuticals is suing Indian-based Intas Pharmaceuticals, alleging that the company has infringed upon its patent rights to anaemia drug, …
Research shows Novartis’s Entresto reduces cardiovascular death and heart failure
April 4, 2016Research and Development, Sales and Marketing Entresto, Novartis, Regeneron, Sanofi, cardiovascular, clinical trial, patent
Novartis has announced results from the PARADIGM-HF clinical trial that show that Entresto (sacubitril/valsartan) consistently demonstrated benefit among heart failure …
Almost half of US physicians will prescribe more biosimilars, according to survey
March 4, 2016Medical Communications Obama, US, biosimilar, patent, prescribing
New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …
The biggest side-effect of making medicine
September 16, 2015Research and Development evergreening, intellectual property, patent
International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people …
Novartis agrees Gleevec patent deal
May 19, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent
Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …
January deadline for Pfizer restructure
July 30, 2013Research and Development, Sales and Marketing Pfizer, patent, restructure
Pfizer is to restructure operations from January 2014 in a bid to make its business more responsive to patient and …
Merck’s Singulair faces generic rivals
August 7, 2012Sales and Marketing Merck, Singulair, generic erosion, patent
Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …
NHS spending on drugs fell in 2011
April 4, 2012Sales and Marketing NHS, cost savings, generic, patent, prescriptions, spend
The NHS in England spent less on its drugs budget last year, bucking the longstanding upward trend. This is because …
Watson submits Crestor copycat
October 28, 2010Sales and Marketing AstraZeneca, Crestor, Watson, generic, patent
Watson Pharmaceuticals is seeking to launch a generic version of AstraZeneca cholesterol blockbuster Crestor, exploiting weaknesses in its patent. The …
Pharma welcomes UK pre-budget report
December 14, 2009Research and Development patent, tax
The pharma and healthcare sectors have been unpicking the implications of last week’s Pre-Budget Report (PBR) by chancellor Alastair Darling.The …
